Cargando…
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective altern...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801968/ https://www.ncbi.nlm.nih.gov/pubmed/35101375 http://dx.doi.org/10.1016/j.transci.2022.103374 |
_version_ | 1784642571643912192 |
---|---|
author | Monteón, Victor Pérez, Floribeth Leon Hernández, Virginia Peña Pacheco, Anatalia Osorio Guzman, Pedro Fuentes Torres, Gicel Ivett Gutiérrez |
author_facet | Monteón, Victor Pérez, Floribeth Leon Hernández, Virginia Peña Pacheco, Anatalia Osorio Guzman, Pedro Fuentes Torres, Gicel Ivett Gutiérrez |
author_sort | Monteón, Victor |
collection | PubMed |
description | At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective alternative to monitor the population’s infection exposure. The aim of the study was to estimate IgG anti-SARS-CoV-2 seropositivity in the Campeche’s main blood bank in Mexico. This was a cross-sectional study carried out at the main blood bank of the State of Campeche, located in the Yucatan peninsula, Mexico for the period of August through September 2021 during the third wave of the epidemic. A blood sample from 479 blood donors were included in the study, the overall seropositivity for SARS-CoV-2 IgG antibodies was 69.1 %. Vaccinated donors represented 69.9 % versus 29.4 % unvaccinated. The seropositivity in unvaccinated represented 42.5 % and 81.17 % in vaccinated. The seroconversion in vaccinated donors after first shot was 79 % for Astra-Zeneca-vaccine and 90 % for Pfizer-vaccine. In conclusion 69.1 % of blood donors are seropositive for SARS-CoV-2 and 42.5 percent unvaccinated people are already also seropositive. |
format | Online Article Text |
id | pubmed-8801968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88019682022-01-31 Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico Monteón, Victor Pérez, Floribeth Leon Hernández, Virginia Peña Pacheco, Anatalia Osorio Guzman, Pedro Fuentes Torres, Gicel Ivett Gutiérrez Transfus Apher Sci Article At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective alternative to monitor the population’s infection exposure. The aim of the study was to estimate IgG anti-SARS-CoV-2 seropositivity in the Campeche’s main blood bank in Mexico. This was a cross-sectional study carried out at the main blood bank of the State of Campeche, located in the Yucatan peninsula, Mexico for the period of August through September 2021 during the third wave of the epidemic. A blood sample from 479 blood donors were included in the study, the overall seropositivity for SARS-CoV-2 IgG antibodies was 69.1 %. Vaccinated donors represented 69.9 % versus 29.4 % unvaccinated. The seropositivity in unvaccinated represented 42.5 % and 81.17 % in vaccinated. The seroconversion in vaccinated donors after first shot was 79 % for Astra-Zeneca-vaccine and 90 % for Pfizer-vaccine. In conclusion 69.1 % of blood donors are seropositive for SARS-CoV-2 and 42.5 percent unvaccinated people are already also seropositive. Elsevier Ltd. 2022-06 2022-01-31 /pmc/articles/PMC8801968/ /pubmed/35101375 http://dx.doi.org/10.1016/j.transci.2022.103374 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Monteón, Victor Pérez, Floribeth Leon Hernández, Virginia Peña Pacheco, Anatalia Osorio Guzman, Pedro Fuentes Torres, Gicel Ivett Gutiérrez Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title | Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title_full | Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title_fullStr | Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title_full_unstemmed | Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title_short | Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
title_sort | seroprevalence of sars-cov-2 antibodies in blood donors during the third wave of infection in campeche mexico |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801968/ https://www.ncbi.nlm.nih.gov/pubmed/35101375 http://dx.doi.org/10.1016/j.transci.2022.103374 |
work_keys_str_mv | AT monteonvictor seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico AT perezfloribethleon seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico AT hernandezvirginiapena seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico AT pachecoanataliaosorio seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico AT guzmanpedrofuentes seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico AT torresgicelivettgutierrez seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico |